SCHALOP LEE TROY purchased 48.54K shares of LANTERN PHARMA INC. on the open market
Open‑market purchase worth $100.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/14/2026ACC: 0001493152-26-023083
0.00
Net shares
Net seller
$100.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
48.54K acquired · 48.54K disposed
Non-Derivative Transactions1
Common stock, $0.001 par value
Direct
Shares
+48.54K
Price / share
$2.06
Trade value
$100K
% of position
New position
5/12/2026
0.00→48.54K
Total
Net shares
+48.54K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.001 par value Direct | 5/12/2026 | P · Purchase | +48.54K | $2.06 | $100K | New position | 0.00 | 48.54K |
| Total | +48.54K | $100K | ||||||
Derivative Transactions1
Common stock purchase warrant (Right to Buy)
Direct
Converts to
Common Stock
48.54K shares
Shares
−48.54K
Strike price
2.27
Held after
48.54K
Exercisable
—
5/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common stock purchase warrant (Right to Buy) Direct | Common Stock48.54K shares | 5/12/2026 | P · Purchase | −48.54K | 2.27 | — | 48.54K |